Sara Kangaspeska

University of Helsinki — Finland

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index2.3kcitations44works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Lipids, and Metabolism(18), Prostate Cancer Treatment and Research(12), Estrogen and related hormone effects(11), Cancer-related molecular mechanisms research(6), Metabolomics and Mass Spectrometry Studies(6)

Publications44 total

Supplementary Table 5 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Supplementary Figures 1-2, Materials, Tables 1-4 and Table 7 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Supplementary Table 6 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Supplementary Figures 1-2, Materials, Tables 1-4 and Table 7 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Data from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Data from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Supplementary Table 6 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Supplementary Table 5 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
2023Open Access
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
Science Advances·2019· 89 citedOpen Access
Association of tamoxifen resistance and lipid reprogramming in breast cancer
BMC Cancer·2018· 211 citedOpen Access
Association of tamoxifen resistance and lipid reprogramming in breast cancer
2018· 26 citedOpen Access
Additional file 3: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 1: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 6: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 7: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 9: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 10: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 2: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 8: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
Additional file 4: of Association of tamoxifen resistance and lipid reprogramming in breast cancer
Figshare·2018Open Access
page 1 of 3Next →

Frequent Co-authors

Olli Kallioniemi(38), Henrik Edgren(24), Susanne Hultsch(21), Daniel Nicorici(16), Päivi Östling(13), Merja Perälä(12), Matti Kankainen(12), Vilja Pietiäinen(12), Suvi‐Katri Leivonen(11), Anna Aakula(11), Pekka Kohonen(11), Rami Mäkelä(11), Zandra Hagman(11), Anders Edsjö(11), Anders Bjartell(11), Yvonne Ceder(11), Lassi Paavolainen(11), Ruusu‐Maaria Kovanen(11), Elina Ikonen(11), Tero Aittokallio(9)